MEDICINES FOR CHILDREN

The EAP Medicines for Children Strategic Advisory Group was established to advocate for equal access to safe, modern and affordable therapeutic medicine options to support diagnosis, treatment and prevention of diseases – especially for children/young persons in Europe.

Burning Issues Include:

• The correct administration of medicine in children (appropriate formulations and the dosage).
• The lack of medicines that are appropriate for, and specifically aimed, at children.
•  Excessive prices of some orphan drugs for rare diseases / high expense low volume medications.
•  The remaining large number of prescriptions of off-label drugs in our patients.
•  Lack of Investment in drugs for specific paediatric indications/needs.
•  Insufficient infrastructure/networks to perform multicentred paediatric trials across Europe.